
Finasteride (0.1% w/v) + Minoxidil (5% w/v)
Active composition
+1 more active ingredient
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Medical applications
Hairgro MF Solution is a topical formulation containing Minoxidil (5% w/v) and Finasteride (0.1% w/v), indicated for the treatment of androgenetic alopecia in both men and women. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular size and prolonging the anagen phase of the hair cycle, thereby increasing hair density and thickness. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combined action of these active ingredients addresses hair thinning through dual mechanisms: stimulating new hair growth and preventing further follicular damage. Hairgro MF Solution is applied topically to the affected scalp areas once daily, ensuring localized delivery with minimal systemic absorption. Clinical studies have demonstrated its efficacy in halting hair loss progression and improving hair count and quality over a treatment period of several months. Patients should adhere to the recommended dosage and consult healthcare professionals prior to use, especially in cases of hypersensitivity, scalp infections, or underlying medical conditions. Adverse effects may include scalp irritation, pruritus, or transient hypertrichosis. Regular monitoring is advised to assess therapeutic response and tolerability.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Hairgro MF Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Hairgro MF Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Hairgro MF Solution

Minoxidil (5% w/v) + Finasteride (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Medical applications
Hairgro MF Solution is a topical formulation containing Minoxidil (5% w/v) and Finasteride (0.1% w/v), indicated for the treatment of androgenetic alopecia in both men and women. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular size and prolonging the anagen phase of the hair cycle, thereby increasing hair density and thickness. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combined action of these active ingredients addresses hair thinning through dual mechanisms: stimulating new hair growth and preventing further follicular damage. Hairgro MF Solution is applied topically to the affected scalp areas once daily, ensuring localized delivery with minimal systemic absorption. Clinical studies have demonstrated its efficacy in halting hair loss progression and improving hair count and quality over a treatment period of several months. Patients should adhere to the recommended dosage and consult healthcare professionals prior to use, especially in cases of hypersensitivity, scalp infections, or underlying medical conditions. Adverse effects may include scalp irritation, pruritus, or transient hypertrichosis. Regular monitoring is advised to assess therapeutic response and tolerability.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Hairgro MF Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Hairgro MF Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Hairgro MF Solution















